The cardiovascular pharmacology of lidoflazine
Schaper, W.; Jageneau, A.; Xhonneux, R.
Bruxelles Medical 50(9): 635-638
1970
ISSN/ISBN: 0068-3027 PMID: 5510364 Document Number: 28779
Document emailed within 1 workday
Related Documents
Lewi, P.J.; Schaper, W.K.; Van Riel, D.G.; Snoeckx, L.H.; Flameng, W.J.; Nuyens, R.F. 1973: The use of a minocomputer in cardiovascular pharmacology Arzneimittel-Forschung 23(3): 436-441Bell, S.G. 1998: Neonatal cardiovascular pharmacology Neonatal Network: Nn 17(2): 7-15
Van Nueten, J.M. 1988: Cardiovascular pharmacology of serotonin and its antagonists Revue Medicale de Liege 43(Suppl 1): 22-30
Gorczynski, R.J.; Wroble, R.W. 1982: Cardiovascular pharmacology of ASL-7022. II. Mechanisms of inotropic selectivity Journal of Pharmacology and Experimental Therapeutics 223(1): 12-19
Osborne, M.W.; Wenger, J.J.; Willems, W. 1971: The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects Journal of Pharmacology and Experimental Therapeutics 178(3): 517-528
Gorczynski, R.J.; Reynolds, R.D. 1985: Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms Journal of Pharmacology and Experimental Therapeutics 232(3): 629-635
Wu, Y.; Fang, D. 1992: Advance in pharmacology of potassium channels in cardiovascular system and their clinical use Zhonghua Yi Xue Za Zhi 72(3): 180-183
Lee, J.Y.; Rozek, L.F.; Sanner, J.H.; Radzialowski, F.M. 1983: Cardiovascular pharmacology of a calcium antagonist antihypertensive agent, SC-30552 Methods and Findings in Experimental and Clinical Pharmacology 5(4): 235-249
Lozinskiĭ, L.G.; Venediktova, M.G.; Zakharova, G.I.; Sandomirskiĭ, B.L. 1986: Development of methods for research on the clinical pharmacology of drugs used in cardiovascular diseases Farmakologiia i Toksikologiia 49(5): 60-62
Otto, C.W. 1986: Cardiovascular pharmacology. II: The use of catecholamines, pressor agents, digitalis, and corticosteroids in CPR and emergency cardiac care Circulation 74(6 Pt 2): Iv80-Iv85
Ferreira, R. 1992: First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 261-264
Atkinson, J.; Capdeville-Atkinson, C.; Chillon, J.M.; Giummelly, P.; Lartaud-Idjouadiene, I. 1998: Cardiovascular aging: physiology, pathology, pharmacology and therapeutics. 23-24 July 1998, Faculty of Pharmacy, Nancy, France IDrugs: the investigational drugs journal 1(6): 650-651
Cosnier, D.; Duchenne-Marullaz, P.; Rispat, G.; Streichenberger, G. 1977: Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound Archives Internationales de Pharmacodynamie et de Therapie 225(1): 133-151
Nakatsuji, K.; Kii, Y.; Fujitani, B.; Ito, T. 1990: General pharmacology of recombinant human tumor necrosis factor. 1st communication: effects on cardiovascular, gastrointestinal, renal and blood functions Arzneimittel-Forschung 40(2 Part 1): 218-225
Schlesinger, P.; Benchimol, A.B. 1972: Lidoflazine in angina pectoris Arquivos Brasileiros de Cardiologia 25(5): 397-403
Dvorák, I.; Zemánková, J.; Soják, K. 1973: Results of treatment of a coronary pain syndrome with lidoflazine Vnitrni Lekarstvi 19(10): 943-948
Afonso, S.; O'Brien, G.S. 1971: Mechanism of enchancement of adenosine action by dipyridamole and lidoflazine, in dogs Archives Internationales de Pharmacodynamie et de Therapie 194(1): 181-196
Brandão, F.; Polónia, J. 1992: Clinical trials in cardiovascular clinical pharmacology Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 273-281
Lehmann, H.U.; Scholle, J.; Hochrein, H. 1974: The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients Münchener Medizinische Wochenschrift 116(46): 2019-2026
De Vil, C.; Bruyneel, K. 1974: Cardioversion and treatment of chronic atrial dysrhythmias with guinidine or lidoflazine: a comparative study Acta Cardiologica 29(5): 383-398